Klotho Neurosciences, Inc. - Common StockShare · US49876K1034 · KLTO (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Klotho Neurosciences, Inc. - Common Stock
No Price
01.05.2026 22:33
Current Prices from Klotho Neurosciences, Inc. - Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
GRML
USD
01.05.2026 22:33
0,51 USD
0,03 USD
+6,94 %
IEX
GRML
USD
01.05.2026 19:59
0,52 USD
0,03 USD
+7,04 %
Share Float & Liquidity
Free Float84,83 %
Shares Float61,49 M
Shares Outstanding72,49 M
Company Profile for Klotho Neurosciences, Inc. - Common Stock Share
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
